Skip to the page

Data / Form D filings / DexCare, Inc.

DexCare, Inc.: Form D filings

DexCare, Inc., a health care company in Seattle, WA, filed 3 Form D notices with the SEC between 2021 and 2026. The latest, on September 14, 2026, reports $12.9 million sold of a $22.7 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1522 Western Ave., #24336, Seattle, WA, 98101
Phone
(253) 302-8469
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1843308

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 14, 2026New notice$22,724,666$12,929,562$9,795,10414Aug 28, 2026sec.gov
Jun 27, 2023New notice$60,000,000$47,189,230$12,810,77010May 26, 2023sec.gov
Mar 10, 2021New notice$19,999,997$19,999,99711Mar 3, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Matthew BloslExecutive Officer, Director
Lynne Chou O'KeefeDirector
Toby CosgroveDirector
Todd CozzensDirector
Branden FiniDirector
Paul MinardiDirector
Caroline XieDirector

Other health care companies in Washington that filed recently

Every Form D from the week of Sep 14, 2026 · All recent filings in Washington · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what DexCare, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.